Stock data
Summit Therapeutics Inc. (SMMT)
Summit Therapeutics Inc. (SMMT) reported net income of -US$1.08B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | — | -US$1.08B | — |
| 2024 | US$0.00M | — | -US$226.00M | -US$221.31M | — |
| 2023 | US$0.00M | — | -US$609.65M | -US$614.93M | — |
| 2022 | US$0.70M | — | -US$72.09M | -US$78.78M | — |
| 2021 | US$1.81M | — | -US$86.19M | -US$88.60M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$215.70M | — |
| 2026-03-31 | — | -US$189.42M | — |
| 2025-12-31 | — | -US$219.17M | — |
| 2025-09-30 | — | -US$231.79M | — |
| 2025-06-30 | — | -US$565.71M | — |
| 2025-03-31 | — | -US$62.91M | — |
| 2024-12-31 | — | -US$61.20M | — |
| 2024-09-30 | US$0.00M | -US$56.25M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.